BackgroundCheck.run
Search For

Britta A Singer, 49Las Vegas, NV

Known as:
Britta C Singer Britta Singer Anderson Bretter Singer Britta A Clinton Britt A Anderson Singer Bretter
Related to:
James H Anderson 32

Britta Singer Phones & Addresses

Las Vegas, NV   

Logandale, NV   

Sparks, NV   

Golden, CO   

Golden, CO   

Lawrence, KS   

6215 Sunkiss Dr, Las Vegas, NV 89110    702-3346298   

Work

Position: Construction and Extraction Occupations

Education

Degree: Graduate or professional degree
Get Report
Control this profile

Mentions for Britta A Singer

Britta Singer resumes & CV records

Resumes

Britta Singer Photo 5

Consultant - Doterra

Location:
6215 Sunkiss Dr, Las Vegas, NV 89110
Industry:
Graphic Design
Work:
Doterra Essential Oils
Consultant Lily and Thistle's Closet
Owner and Homemaker Britta's Boutique
Owner Art Image Mar 1998 - Mar 1999
Graphic Designer and Installer Essential Oils Mar 1998 - Mar 1999
Consultant - Doterra
Education:
Brigham Young University - Idaho 1993 - 1995
Associates, Associate of Arts, Graphic Design Ricks College
Skills:
Microsoft Office, Excel, Customer Service, Word, Customer Relations, Adobe Illustrator, Adobe Photoshop, Social Media, Graphics, Logo Design, Teaching, Entrepreneurship, Social Media Marketing
Interests:
Cooking/Baking
Jewelry Making
Decorating My Home
Quilting
Design Shirts For My Kids
Creating Hair Accessories
Etc
Sewing
Wall Hangings
Britta Singer Photo 6

Self Employed At Shelf Reliance

Location:
Las Vegas, NV
Industry:
Food Production
Work:
Thrive Life
Self Employed at Shelf Reliance
Britta Singer Photo 7

Britta Singer

Location:
Las Vegas, NV
Industry:
Health, Wellness And Fitness
Work:
Doterra
Independent Consultant
Britta Singer Photo 8

Britta Singer

Location:
Las Vegas, NV
Industry:
Health, Wellness And Fitness

Publications & IP owners

Us Patents

Cardiovascular Risk Event Prediction And Uses Thereof

US Patent:
2013008, Apr 4, 2013
Filed:
Sep 28, 2012
Appl. No.:
13/631567
Inventors:
Stephen Alaric WILLIAMS - Boulder CO, US
Alex A.E. STEWART - Waltham MA, US
Robert MEHLER - Boulder CO, US
Trudi FOREMAN - Boulder CO, US
Britta SINGER - Boulder CO, US
Assignee:
SOMALOGIC, INC. - Boulder CO
International Classification:
C40B 30/04
C40B 40/06
C40B 40/10
US Classification:
506 9, 506 18, 506 16
Abstract:
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2. In a further aspect, methods are provided for evaluating the risk of a CV event in an individual, generally within 5 years, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 3.

Cardiovascular Risk Event Prediction And Uses Thereof

US Patent:
2020016, May 28, 2020
Filed:
Jan 23, 2020
Appl. No.:
16/751102
Inventors:
- Boulder CO, US
Stephen Alaric WILLIAMS - Boulder CO, US
Alec A.E. STEWART - Waltham MA, US
Robert MEHLER - Boulder CO, US
Trudi FOREMAN - Boulder CO, US
Britta SINGER - Boulder CO, US
Assignee:
SomaLogic, Inc. - Boulder CO
International Classification:
G01N 33/68
Abstract:
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2. In a further aspect, methods are provided for evaluating the risk of a CV event in an individual, generally within 5 years, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 3.

Compositions And Methods For Identifying, Modulating And Monitoring Drug Targets In Muscular Disease

US Patent:
2018028, Oct 4, 2018
Filed:
Jan 24, 2018
Appl. No.:
15/878504
Inventors:
- Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
David Sterling - Boulder CO, US
Edward Brody - Boulder CO, US
Britta Singer - Boulder CO, US
Robert Mehler - Boulder CO, US
Assignee:
SomaLogic, Inc. - Boulder CO
International Classification:
G01N 33/68
A61K 38/18
A61K 45/06
Abstract:
The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).

Compositions And Methods For Identifying, Modulating And Monitoring Drug Targets In Muscular Disease

US Patent:
2016032, Nov 10, 2016
Filed:
May 2, 2016
Appl. No.:
15/144593
Inventors:
- Boulder CO, US
Kirk DeLisle - Boulder CO, US
David Sterling - Boulder CO, US
Edward Brody - Boulder CO, US
Britta Singer - Boulder CO, US
Robert Mehler - Boulder CO, US
International Classification:
A61K 38/18
G01N 33/68
A61K 45/06
Abstract:
The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).

Cardiovascular Risk Event Prediction And Uses Thereof

US Patent:
2015016, Jun 18, 2015
Filed:
Dec 31, 2013
Appl. No.:
14/145026
Inventors:
- Boulder CO, US
Stephen Alaric WILLIAMS - Boulder CO, US
Alex A.E. STEWART - Waltham MA, US
Robert MEHLER - Boulder CO, US
Trudi FOREMAN - Boulder CO, US
Britta SINGER - Boulder CO, US
Assignee:
SOMALOGIC, INC. - Boulder CO
International Classification:
G01N 33/68
Abstract:
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2. In a further aspect, methods are provided for evaluating the risk of a CV event in an individual, generally within 5 years, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 3.

Possible Relatives

Cynthia M Singer  David A Singer  Deanna A Singer  Dale R Singer  Debbi L Singer  Debbie G Singer  Deborah E Singer  Britta A Johnson  Britta Jones  Britta M Kennedy 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.